EU Biotech Act Aims to Boost European Innovation

The proposed EU Biotech Act seeks to address regulatory fragmentation and streamline procedures within the European biotechnology sector. It aims to bolster Europe’s competitiveness in global biotechnology by supporting innovation from research to patient access. Successful implementation is crucial to maintaining Europe’s position and accelerating access to new treatments, particularly given the region’s declining share of pharmaceutical investment.

Summarized from the sources above. Read the originals for the full story.